FIGS GAAP EPS of $0.10 beats by $0.03, revenue of $190.7M beats by $7.87M (NYSE:FIGS)
FIGS reported Q3 GAAP EPS of $0.10, exceeding estimates by $0.03, with revenue of $190.7M, up 25.7% year-over-year and beating by $7.87M. The company forecasts Q4 revenue growth of ~15% and FY 2026 adjusted EBITDA margin of ~15.8%. Shares fell 4.9% after hours.
How this was made
The 30-second read
Why it matters
The earnings beat was modest and the stock fell 4.9% after hours, suggesting limited upside.
Market read
First‑report earnings for a mid‑cap US health‑tech stock; relevant for short‑term traders.
What to watch
Potential upside from upcoming product launches and expanding wholesale partnerships not reflected in the release.
Background
FIGS released its Q3 earnings, reporting a small GAAP EPS beat and revenue beat.
Ticker impact
Q3 GAAP EPS of $0.10 beats expectations by $0.03 and revenue of $190.7M beats by $7.87M.
likely pressure as the market prices in the modest beat and guidance outlook.
Earnings beat was small and guidance suggests modest growth; the stock already slipped 4.9% AH, indicating downside bias.
Market effects
Medical apparel sector may see modest upside from the beat but overall sentiment remains cautious.
US market participants may adjust short-term positioning in FIGS and similar mid‑cap health‑tech stocks.
Limited to investors tracking US mid‑cap earnings; no broader macro impact.
Counterpoint
The beat could be a catalyst for a short‑term bounce if investors overreact to the modest miss on guidance.
Key entities
- companyFIGS
US‑listed medical apparel retailer (NYSE:FIGS).
